- Anniversary/History
- Membership
- Publications
- Resources
- Education
- Events
- Outreach
- Careers
- About
- For Pain Patients and Professionals
Papers: 11 Mar 2023 - 17 Mar 2023
RESEARCH TYPE:
Basic Science
Animal Studies, Ex Vivo Studies, Neurobiology, Pharmacology/Drug Development
PAIN TYPE:
Neuropathic Pain
2023 Mar 13
Pharmacol Rep
Recently, we have reported an isatin-derived carbohydrazone, 5-chloro-N’-(6-chloro-2-oxoindolin-3-ylidene)-2-hydroxybenzohydrazide (SIH 3) as dual nanomolar FAAH (fatty acid amide hydrolase)-MAGL (monoacylglycerol lipase) inhibitor with good CNS penetration and neuroprotective activity profile. In this study, we further investigated the pharmacological profile of compound SIH 3 in the neuropathic pain model along with acute toxicity and ex vivo studies.